Expression control using antibody expression optimisation sequences
View Patent ↗The present invention provides a dicistronic message for producing an antibody molecule, in which the upstream cistron contains DNA coding for the light chain of the antibody and the downstream cistron contains DNA coding for the corresponding heavy chain, characterised in that the dicistronic message comprises a sequence selected from AEOS1 (SEQ ID NO:1), AEOS2 (SEQ ID NO:2), AEOS3 (SEQ ID NO:3), AEOS4 (SEQ ID NO: 4), AEOS5 (SEQ ID NO:5), AEOS6 (SEQ ID NO:6), AEOS7 (SEQ ID NO:7), AEOS8 (SEQ ID NO:8), AEOS9 (SEQ ID NO:9), AEOS1O (SEQ ID NO:10) and AEOS11 (SEQ ID NO:11).
1. A dicistronic message for producing an a recombinant antibody molecule, in which the upstream cistron contains DNA coding for the light chain of the recombinant antibody and the downstream cistron contains DNA coding for the corresponding heavy chain, characterised in that the two cistrons are linked by an intergenic sequence (IGS), wherein the IGS is selected from IGS5 (SEQ ID NO: 12), IGS8 (SEQ ID NO: 13), IGS9 (SEQ ID NO:14), IGS10 (SEQ ID NO:15), IGS11 (SEQ ID NO:16), IGS12 (SEQ ID NO:17), IGS 13 (SEQ ID NO:18), IGS14 (SEQ ID NO: 19), IGS15 (SEQ ID NO:20), IGS16 (SEQ ID NO:21), IGS17 (SEQ ID NO:22) and IGS18 (SEQ ID NO:23).
2. The dicistronic message according to claim 1 in which the light chain of the recombinant antibody molecule encoded by the message comprises the sequence given in SEQ ID NO:24 and the heavy chain of the recombinant antibody molecule encoded by the message comprises the sequence given in SEQ ID NO:25.
3. The dicistronic message according to claim 2 in which the message comprises the sequence given in SEQ ID NO:26.
4. An isolated expression vector containing a dicistronic message according to claim 1 .
5. An isolated expression vector according to claim 4 , wherein the expression vector is pTTO-1.
6. An isolated host cell that has been transformed with an expression vector according to claim 4 .